[email protected]   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Preclinical Imaging Market Share

ID: MRFR//5896-HCR | 110 Pages | Author: Rahul Gotadki| September 2025

Introduction: Navigating the Competitive Landscape of Preclinical Imaging

The preclinical image market is currently being shaped by rapid technology developments, regulatory changes, and the expectations of research institutions and pharmaceutical companies. The market leaders, primarily manufacturers, IT service companies, and innovative AI start-ups, are vying for leadership by deploying the most advanced imaging modalities and integrating artificial intelligence-based image analysis for more precise diagnosis. Meanwhile, the leading suppliers of equipment are focusing on automation and the Internet of Things to optimize work processes, and new entrants are introducing biometric and green IT solutions to meet the requirements of sustainable development. Moreover, given the uneven development of the regional markets, especially in North America and Asia-Pacific, strategic alliances and acquisitions are increasingly favored in order to enhance technological capabilities and reach more customers. These interrelated forces are critical for all market participants who wish to maintain a competitive edge in the preclinical image market.

Competitive Positioning

Full-Suite Integrators

These companies offer complete solutions that combine different imaging modalities and different methods for preclinical research.

VendorCompetitive EdgeSolution FocusRegional Focus
Bruker Corporation Broad range of imaging technologies Multimodal imaging systems Global
PerkinElmer Strong focus on life sciences applications Imaging and analysis solutions North America, Europe
Fujifilm Holdings Corporation Innovative imaging technologies Medical imaging solutions Asia, North America

Specialized Technology Vendors

These companies concentrate on the specialization of the image, providing solutions for preclinical applications.

VendorCompetitive EdgeSolution FocusRegional Focus
MR Solutions Expertise in MRI technology MRI preclinical imaging Global
Milabs B.V. Advanced molecular imaging capabilities PET/SPECT imaging systems Europe, North America
Miltenyi Biotec GmbH Focus on cell and gene therapy imaging Cellular imaging solutions Global
Aspect Imaging Compact and user-friendly systems High-resolution MRI systems Global

Infrastructure & Equipment Providers

These suppliers provide essential preclinical imaging equipment and systems.

VendorCompetitive EdgeSolution FocusRegional Focus
Mediso Ltd. Integrated imaging solutions Hybrid imaging systems Europe, Asia
LI-COR Inc. Innovative fluorescence imaging technology Fluorescence imaging systems North America, Europe
Trifoil Imaging Specialization in gamma imaging Gamma imaging systems Global

Emerging Players & Regional Champions

  • NanoScan Imaging (US): Provides high-resolution microscopy for small animal models. It has recently signed a contract with a leading pharmaceutical company for preclinical testing. NanoScan complements established suppliers with its more cost-effective and compact systems.
  • Bruker (Germany): Offers advanced imaging techniques, including MRI and PET, for preclinical research, recently established a partnership with a major university, and competes with established suppliers by offering better imaging capabilities and software integration.
  • PerkinElmer, Inc. (USA): specializes in in vivo imaging and molecular imaging. Its new platform, which enhances resolution and sensitivity, fills gaps in the capabilities of established companies.
  • Miltenyi Biotec (Germany): Provides integrated imaging solutions for cell and gene therapy. It has recently expanded its product line to include preclinical image systems, thereby challenging established suppliers in their own specialized niches.
  • The PET system of Sofie Biosciences, adapted to the needs of preclinical research, recently entered into a partnership with a biotech company for the development of drugs, and thus complements the established suppliers by offering a specialized solution for specific research needs.

Regional Trends: In North America, the tendency to adopt the latest imaging technology is strong and is supported by considerable investment in research and development. Europe is experiencing a growing trend towards collaboration between academic institutions and small companies developing specific imaging solutions. In the Asia-Pacific region, and particularly in China and India, the demand for cost-effective imaging solutions is increasing. This has led to the emergence of new local players specializing in cost-effective solutions.

Collaborations & M&A Movements

  • Bruker and PerkinElmer have agreed to combine their advanced imaging technologies in order to further develop their preclinical research capabilities and to strengthen their market position in the life sciences sector.
  • In early 2024, the biotechnology company Biovant was acquired by Siemens Healthineers to expand its preclinical imaging solutions and thus increase its market share in the fast-growing field of biopharmaceutical research.
  • This is a joint statement from Fujifilm and Invicro on the development of new biomarkers for drug development. This will broaden the range of products and services available to customers, and will enhance the companies' position in the preclinical imaging market.

Competitive Summary Table

CapabilityLeading PlayersRemarks
High-Resolution Imaging Bruker Corporation, PerkinElmer Bruker offers advanced MRI and PET systems for preclinical studies. PerkinElmer’s imaging solutions are distinguished by their sensitivity and specificity and enable the precise visualization of biological processes.
Multimodal Imaging Siemens Healthineers, GE Healthcare This means that a single X-ray session with PET, X-ray, and MRI is sufficient for a comprehensive diagnosis. GE's multi-mode platforms support preclinical research in many ways.
In Vivo Imaging Miltenyi Biotec, Fujifilm VisualSonics Miltenyi Biotec is a company that develops in vivo optical systems that enable the real-time monitoring of the progress of the disease. Fujifilm VisualSonics develops high-resolution ultrasound systems that are particularly useful for small animal experiments.
Data Analysis Software PerkinElmer, Invicro PerkinElmer's software solutions offer powerful data analysis tools for interpreting complex images, while Invicro's platform is known for its advanced image processing and quantification algorithms.
Sustainability Practices Bruker Corporation, Siemens Healthineers Bruker is committed to reducing its waste by reusing its imaging process. Siemens Healthineers has also made a commitment to developing eco-friendly products, in line with its global commitment to sustainability.
User-Friendly Interfaces GE Healthcare, Fujifilm VisualSonics The GE Healthcare Research department has focused on developing intuitively easy-to-use interfaces that simplify the process of research. The Fujifilm VisualSonics department has also focused on making its applications easy to use.

Conclusion: Navigating the Competitive Landscape Ahead

Towards 2024, the market for preclinical imaging is characterized by a highly competitive landscape, with both legacy and newcomers vying for market share. In terms of regional trends, North America and Europe are becoming more and more receptive to innovation, while Asia-Pacific is quickly becoming the main area for new entrants. Strategically, vendors are focusing on deploying advanced capabilities such as AI, automation, and green technology to enhance their offerings and operational efficiencies. To maintain leadership in this evolving landscape, a company’s ability to respond to customer needs and provide flexible solutions will be paramount. In this context, strategic alliances and investments in key areas are required to maintain a competitive advantage and to meet the increasing demands of the market.

Covered Aspects:
Report Attribute/Metric Details
Base Year For Estimation 2022
Historical Data 2018 - 2021
Forecast Period 2023-2030
Growth Rate 3.20% (2023-2030)
Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.